Ken oversees HSP's client engagement, ensuring excellence at every point of contact. He has 20 years of global strategy and market research experience within a nearly 30-year healthcare career.
Ken specializes in holistic, evidence-based solutions supporting biopharma investment, development, launch, and commercialization decisions and is particularly adept at understanding and developing strategy to influence healthcare decision making by physicians, patients, payers, and other key stakeholders.
Ken has applied HSP’s advise-to-operate approach successfully to hundreds of due diligence and launch/brand/LCM strategy engagements.
His client partnerships have covered most major therapeutic areas and geographic regions, as well as many less common rare diseases and emerging markets.
Prior to Healthcare Strategy Partners, Ken held executive and account leadership positions at IQVIA, Quintiles, and Eidetics.
Ken holds a Ph.D. with highest honors from State University of New York, Stony Brook and is currently licensed in Clinical Psychology. He furthered his studies at Harvard Medical School where he is also an instructor, as well as completing fellowships in Clinical Psychology and Research at Mass General Hospital's National Science Foundation.